Brief: Atea Pharmaceuticals Reports Data On Bemnifosbuvir
02/02/2022 12:09
Feb 2 (Reuters) - Atea Pharmaceuticals Inc AVIR.O :
* ATEA PHARMACEUTICALS ANNOUNCES PUBLICATION OF DATA
SUPPORTING
BEMNIFOSBUVIR’S (AT-527) NOVEL MECHANISM OF ACTION AGAINST
SARS-COV-2 IN NATURE COMMUNICATIONS
Source text for Eikon: ID:nGNX1cmvBW
Further company coverage: AVIR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Atea Pharmaceuticals
See all newsAtea Pharmaceuticals Q2 loss narrows as HCV trial expenses decline
Atea Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Atea Pharmaceuticals, Inc. expected to post a loss of 56 cents a share - Earnings Preview
Atea Pharmaceuticals, Inc. expected to post a loss of 56 cents a share - Earnings Preview
NASDAQ RESUMED AT 07:30 AM